Remarkably, inactivation of SETD2 has been found in cell lines of ccRCC and clinical samples in which SETD2 has been demonstrated to function as a tumor suppressor gene in renal cell carcinoma [10, 21]. Here, SETD2 is linked to nonpapillary renal cell carcinoma.